NVAC Influenza Working Group: Preliminary Report Charles Helms, M.D., Ph.D. June 1, 2004.

Slides:

Advertisements

Similar presentations

1 Industry Brief Apr Outline How is Alberta preparing? How is Alberta preparing? Albertas Health Response Albertas Health Response Albertas Operational.

Advertisements

DSHS Immunization Activities to Raise Texas Vaccine Coverage Levels Jack Sims, Manager Immunization Branch September 19, 2006.

New Technologies for Tuberculosis Control: Programme Perspective Draft Definitions Retooling Task Force Meeting Geneva, Switzerland January 2008.

Vaccines and Related Biological Products

The NVPO Unmet Needs Program: FY 2006 Update Ben Schwartz National Vaccine Program Office National Vaccine Advisory Committee Meeting, June 2006.

California Child Welfare Co-Investment Partnership Children’s Conference Monterey, California May 29, 2008.

New York State Workforce Investment Board Healthcare Workforce Development Subcommittee Planning Grant Overview.

Global Vaccines 202X : Access, Equity, Ethics Panel discussion: Pandemic Influenza Preparedness Framework for the sharing of Influenza Viruses and Access.

1. 2 The Public Health Agency of Canada Pandemic Influenza Preparedness: An Overview Dr. Paul Gully Deputy Chief Public Health Officer Ottawa, 19 January.

TM Aggregate Reporting of Pandemic Influenza Vaccine Doses Administered Planning for Seasonal Influenza Pilot Test as Proxy Using CDC's Countermeasure.

Preparing Small Business Workplaces for Pandemic Flu.

HealthSanté CanadaCanada Influenza Prevention and Control in Canada Arlene King, MD, MHSc, FRCPC Director, Immunization and Respiratory Infections Division,

The National Vaccine Plan Process - Update October 22, 2007 Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human Services.

Childhood TB Subgroup of the DEWG: update on policy recommendations Robert Gie Chairperson, Childhood TB Subgroup 31 October 2006 IUATLD Symposium: from.

ATP NVAC PIWG Report Pandemic Influenza Antiviral Strategies and Priority Groups Andrew T. Pavia M.D. University of Utah.

Immunization in the Time of H1N1 Anne Schuchat, MD Rear Admiral, US Public Health Service Director, National Center for Immunization and Respiratory Diseases.

Targeting Prevention to Evidence Based, High Impact Interventions in Medicare George Isham, M.D., M.S. Chief Health Officer AHRQ Annual Conference Bethesda,

THE NATIONAL INFLUENZA VACCINE SUMMIT: UPDATE Raymond A. Strikas, M.D. Immunization Services Division National Immunization Program Coordinating Center.

Vaccines for Children Program Stockpile Status National Vaccine Advisory Committee February 4, 2010 Washington, DC Lance E Rodewald, MD Director, Immunization.

Canterbury Flu Group Shorter ED Stays Winter Planning April 2013.

Needs and Recommendations for the United States Poliovirus Vaccine Stockpile Report of the Joint Working Group of the National Vaccine Advisory Committee.

IOM Report on Financing Vaccines in the 21 st Century: National Vaccine Advisory Committee Follow-up Alan R. Hinman, MD, MPH Chair, NVAC Workgroup on IOM.

Office of Public Health Preparedness and Response Division of Strategic National Stockpile Ben Erickson Public Health Analyst Inventory Management Tracking,

Food and Drug Administration

U.S. Pandemic Influenza Preparedness and Response: Update & Progress Report “The pandemic influenza clock is ticking. We just don’t know what time it is.”

Implementation of HPV Vaccine Claire Hannan, MPH Executive Director, AIM NVAC September 26, 2006.

America Responds: An HHS 2009-H1N1 Retrospective to Advance All Hazards Preparedness Discussion with the National Vaccine Advisory Committee June 3, 2010.

1 Influenza Pandemic Preparedness in Thailand: Cooperation between Public and Private sectors APEC Virtual Symposium 30 May 2008 Bureau of Emerging Infectious.

Financing Administration of 2009 H1N1 Influenza Vaccine Megan C. Lindley, MPH National Center for Immunization and Respiratory Diseases July 27, 2009.

National Vaccine Advisory Committee Report from the Chair Gus Birkhead, MD, MPH NVAC Chair June 2, 2010.

National Vaccine Advisory Committee Report from the Chair Gus Birkhead, MD, MPH NVAC Chair February 3, 2010.

The Influenza Immunization Season: An Early Look at Communications and Media Planning Glen Nowak, Ph.D. Director, Media Relations Centers for Disease.

DRAFT PIP Framework Partnership Contribution: Factors to consider in selecting countries DRAFT PIP Framework Partnership Contribution: Factors to consider.

DATE POWER 2 INCOME JANUARY 100member X 25.00P2, FEBRUARY 200member X 25.00P5, MARCH 400member X 25.00P10, APRIL 800member.

NVAC Influenza Vaccine Recommendations and Strategies Subgroup Members: Jerome Klein (Chair), Jeff Davis, Jon Abramson, Carolyn Bridges, Nancy Cox, Ben.

Pandemic Vaccines Current and Future Issues 30 January 2007 Beijing Keiji Fukuda Global Influenza Programme.

Establishing a Global Vaccine Development Fund Peter Hale The Foundation for Vaccine Research Washington, DC Consultation on Financing of R&D Preparedness.

Strengthening the Delivery of New Vaccines for Adolescents A National Stakeholders' Meeting Washington DC June 2-3, 2005.

FDA’s Role in Facilitating the Availability of Influenza Vaccine Norman W. Baylor, Ph.D. Director, Office of Vaccines Research and Review CBER/FDA.

OVERVIEW OF THE NATIONAL INFLUENZA VACCINE SUMMIT Dennis J. O’Mara Associate Director for Adult Immunization Immunization Services Division National Immunization.

NVAC Influenza Working Group Vaccine Research, Development and Production.

Planning for the Influenza Season National Vaccine Advisory Committee February 8, 2005 Washington, DC Lance E. Rodewald, MD Director, Immunization.

1 NVAC Washington, D.C. February 3, Agenda I.Overview of Influenza Vaccine Production and Development II.Vaccine Supply/Demand: Recent Trends.

Update from the 2010 National Influenza Vaccine Summit meeting L.J Tan Co-chair, National Influenza Vaccine Summit Director, Medicine and Public Health,

Adult Immunization: Goals, Challenges, and a role for the National Vaccine Advisory Committee October 22, 2007 Raymond A. Strikas, MD National Vaccine.

Julie Morita, M.D. NVAC Member Co-Chair, Adult Working Group.

The National Vaccine Plan Update: Recent Activities and Next Steps Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human.

1. Connecting Health Plans and Public Health to Improve Vaccine Delivery CDC Billing Project Billing Planning All-Projects’ Conference Call June 26, 2012;

NVAC Vaccine Safety Risk Assessment Working Group (VSRAWG) Update NVAC Meeting February 3, 2010 Marie McCormick, M.D., Sc.D. Sumner and Esther Feldberg.

The NVPO Unmet Needs Program: Looking Back and Moving Forward Ben Schwartz National Vaccine Program Office National Vaccine Advisory Committee Meeting,

Carol Friedman, D.O. Associate Director for Adult Immunization Immunization Services Division National Center for Immunization and Respiratory Diseases.

2007 National Health Policy Conference Preparing to Protect: Flu Vaccines from Production to Consumption A Public Health Perspective Daniel Hopfensperger.

Pandemic Influenza Planning for Maryland Schools Tiffany Tate, MHS Maryland Partnership for Prevention, Inc. National Immunization Conference March 7,

Ann Intern Med. 2007;147(10): doi: / Figure Legend:

Influenza Vaccine Communication for the Season: Snapshot of Key Messages, Events and Potential Challenges.

Some Perspectives on Vaccination of Adults

Cost of Service Analysis & Rate Design

Pandemic Influenza Preparedness Planning

Stakeholder Consultation

Secretary’s Task Force on Black & Minority Health, 1985

Immunizing the Older Adult: Challenges and Opportunities

ACIP Recommended Vaccines for Adults – By Age

Peng-jun Lu, MD, PhD1; Mei-Chun Hung, MPH, PhD1,2 ; Alissa C

Craig Conlon MD, PhD, Employee Health Services Northern California

Impact if New Jersey Achieved Top-State Rates

Finnian Hanrahan Infectious diseases and public health

An Enabling Business Environment and A Strategic Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,

Updating the National Vaccine Plan: A roadmap for the next decade A National, not Federal, Plan December 11, 2009.

Contribution of Vaccines to Life-Course Event-Free Health

Broader Horizons for Immunization:

Presentation transcript:

NVAC Influenza Working Group: Preliminary Report Charles Helms, M.D., Ph.D. June 1, 2004

NVAC Agenda - February, 2004 Influenza : Review and Lessons Learned for the Next Year and the Future The Current Season Vaccine Strain Selection Process and Regulatory Issues Public Perceptions Perspectives of Influenza Vaccine Manufacturers Public Sector Roles in Adult and Childhood Influenza Vaccination CMS Company perspectives Health Plans and Insurers Vaccine Research – NIH Pandemic Influenza Preparedness

The U.S.National Vaccine Plan Develop new and improved vaccines Ensure the optimal safety and effectiveness of vaccines and immunization Better educate the public and members of the health professions on the benefits and risks of immunizations Achieve better use of existing vaccines to prevent disease, disability, and death.

NVAC Influenza Vaccine WG Purpose: Evaluate strategies and capabilities to reduce the impact of influenza disease in the US and make recommendations on how to substantially improve prevention and reduce disease burden. A preliminary report will be presented at the June 2004 NVAC meeting. Purpose: Evaluate strategies and capabilities to reduce the impact of influenza disease in the US and make recommendations on how to substantially improve prevention and reduce disease burden. A preliminary report will be presented at the June 2004 NVAC meeting.

NVAC Influenza WG Subgroups Influenza Vaccine Research, Development and Production: A. Arvin, Chair Influenza Vaccine Recommendations and Strategies: J. Klein, Chair Influenza Vaccine Delivery, Financing, and Demand: F. Guerra, Chair

Efforts to Date WG and SG conference calls: discussion and coordination Influenza Summit (Atlanta) Discussions with industry Preliminary report to NVAC on June 1

Next Steps WG and SG telephone conference calls – June - August Prepare draft report – September Present draft at NVAC meeting – October